Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

[Endocannabinoid system and bowel inflammation].

Márquez L, Abanades S, Andreu M.

Med Clin (Barc). 2008 Oct 18;131(13):513-7. Review. Spanish.

PMID:
19007582
2.

Endocannabinoids and the gastrointestinal tract: what are the key questions?

Sanger GJ.

Br J Pharmacol. 2007 Nov;152(5):663-70. Epub 2007 Sep 3. Review.

3.

The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.

Fride E.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):24-30. Review.

PMID:
15159678
4.
5.

Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation.

Wright KL, Duncan M, Sharkey KA.

Br J Pharmacol. 2008 Jan;153(2):263-70. Epub 2007 Oct 1. Review.

6.

Gut feelings about the endocannabinoid system.

Di Marzo V, Piscitelli F.

Neurogastroenterol Motil. 2011 May;23(5):391-8. doi: 10.1111/j.1365-2982.2011.01689.x.

PMID:
21481098
7.

Cannabinoid receptors and endocannabinoids: evidence for new players.

Mackie K, Stella N.

AAPS J. 2006 Apr 28;8(2):E298-306. Review.

8.

Endocannabinoids in the gastrointestinal tract.

Lee Y, Jo J, Chung HY, Pothoulakis C, Im E.

Am J Physiol Gastrointest Liver Physiol. 2016 Oct 1;311(4):G655-G666. doi: 10.1152/ajpgi.00294.2015. Epub 2016 Aug 18. Review.

9.

Endocannabinoids and the gastrointestinal tract.

Massa F, Monory K.

J Endocrinol Invest. 2006;29(3 Suppl):47-57. Review.

PMID:
16751708
10.

[A role for the endocannabinoid system in hepatic steatosis].

Valenzuela C, Castillo V, Ronco AM, Aguirre C, Hirsch S, Llanos M.

Rev Med Chil. 2014 Mar;142(3):353-60. doi: 10.4067/S0034-98872014000300010. Review. Spanish.

11.

Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.

Jiang S, Fu Y, Williams J, Wood J, Pandarinathan L, Avraham S, Makriyannis A, Avraham S, Avraham HK.

PLoS One. 2007 Jul 25;2(7):e641.

12.

[Endocannabinoid system: from metabolic to neuroendocrine effects].

Bricaire L, Brue T.

Ann Endocrinol (Paris). 2007 Jun;68 Suppl 1:12-7. French. Erratum in: Ann Endocrinol (Paris). 2008 Nov;69(5):459-60.

PMID:
17961655
13.

Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work?

Immenschuh S.

Cardiovasc Res. 2009 Dec 1;84(3):341-2. doi: 10.1093/cvr/cvp339. Epub 2009 Oct 9. No abstract available.

PMID:
19819883
14.

Endocannabinoid overactivity and intestinal inflammation.

Di Marzo V, Izzo AA.

Gut. 2006 Oct;55(10):1373-6.

15.

The cannabinoid system and immune modulation.

Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H.

J Leukoc Biol. 2003 Oct;74(4):486-96. Epub 2003 Jul 1. Review.

PMID:
12960289
16.

Role of cannabinoid CB2 receptors in glucose homeostasis in rats.

Bermudez-Silva FJ, Sanchez-Vera I, Suárez J, Serrano A, Fuentes E, Juan-Pico P, Nadal A, Rodríguez de Fonseca F.

Eur J Pharmacol. 2007 Jun 22;565(1-3):207-11. Epub 2007 Apr 20.

PMID:
17499236
17.

CB2 receptors in reproduction.

Maccarrone M.

Br J Pharmacol. 2008 Jan;153(2):189-98. Epub 2007 Sep 10. Review.

18.

The Role of the Endocannabinoid System in the Brain-Gut Axis.

Sharkey KA, Wiley JW.

Gastroenterology. 2016 Aug;151(2):252-66. doi: 10.1053/j.gastro.2016.04.015. Epub 2016 Apr 29. Review.

19.

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

Mukhopadhyay S, Tulis DA.

Cardiovasc Hematol Agents Med Chem. 2007 Oct;5(4):311-8. Review.

20.

Supplemental Content

Support Center